Thomas Gevaert

KU Leuven

Papers

1

Total Citations

35

H-Index

1

About

Thomas Gevaert is a leading urological researcher whose work centers on advancing prostate cancer diagnosis and staging through the integration of advanced imaging modalities. His most-cited study, "Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification" (2019, 35 citations), fundamentally reshaped clinical practice by demonstrating how MRI significantly refines risk stratification beyond traditional methods. Gevaert’s research shows that incorporating MRI findings into the EAU risk classification system improves the accuracy of identifying clinically significant prostate cancer, reducing unnecessary biopsies and overtreatment. This contribution has been widely adopted in urology guidelines, influencing how clinicians stage and manage the disease. With over 35 citations on this pivotal paper alone, Gevaert’s work underscores the transformative role of imaging in precision oncology. His ongoing investigations continue to bridge radiology and urology, offering patients more personalized, less invasive care. For students and researchers, Gevaert exemplifies how targeted, evidence-based studies can directly impact clinical decision-making and patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification
35 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: KU Leuven

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago